International Medical Center of Biomaterials Processing and Cryostorage (MOEX: GEMA)
Russia
· Delayed Price · Currency is RUB 672.00
-1.50 (-0.22%)
At close: Jul 8, 2022
GEMA Income Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2015 |
| Revenue | - | 254.68 | 265.89 | 242.63 | 238.59 | 242.64 | Upgrade
|
| Revenue Growth (YoY) | - | -4.22% | 9.59% | 1.69% | -1.67% | 14.64% | Upgrade
|
| Cost of Revenue | - | 51.67 | 61.82 | 30.87 | 18.89 | 20.06 | Upgrade
|
| Gross Profit | - | 203 | 204.07 | 211.76 | 219.7 | 222.58 | Upgrade
|
| Selling, General & Admin | - | 64.41 | 65.52 | 53.69 | 69.24 | 52.97 | Upgrade
|
| Other Operating Expenses | - | - | - | 5.81 | 7.72 | 8.29 | Upgrade
|
| Operating Expenses | - | 64.68 | 66.17 | 69.9 | 82.28 | 67.83 | Upgrade
|
| Operating Income | - | 138.32 | 137.9 | 141.86 | 137.43 | 154.74 | Upgrade
|
| Interest Expense | - | -17.62 | -3.52 | -6.84 | -4.68 | -1.31 | Upgrade
|
| Interest & Investment Income | - | 10.54 | 17.48 | 2.24 | 5.23 | 5.65 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0.09 | - | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -31.72 | -18.7 | -14.39 | -18.71 | -17.3 | Upgrade
|
| EBT Excluding Unusual Items | - | 99.52 | 133.17 | 122.77 | 119.26 | 141.76 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -1.35 | -4 | - | - | - | Upgrade
|
| Pretax Income | - | 98.17 | 129.17 | 122.77 | 119.26 | 141.76 | Upgrade
|
| Net Income | - | 98.17 | 129.17 | 122.77 | 119.26 | 141.76 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | -21.57 | - | - | - | Upgrade
|
| Net Income to Common | - | 98.17 | 150.74 | 122.77 | 119.26 | 141.76 | Upgrade
|
| Net Income Growth | - | -24.00% | 5.21% | 2.95% | -15.88% | 6.80% | Upgrade
|
| Shares Outstanding (Basic) | - | 15 | 15 | 15 | 13 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | - | 15 | 15 | 15 | 13 | 13 | Upgrade
|
| Shares Change (YoY) | - | - | 0.00% | 11.11% | 5.88% | -0.00% | Upgrade
|
| EPS (Basic) | - | 6.58 | 10.10 | 8.22 | 8.88 | 11.17 | Upgrade
|
| EPS (Diluted) | - | 6.58 | 10.10 | 8.22 | 8.88 | 11.17 | Upgrade
|
| EPS Growth | - | -34.88% | 22.79% | -7.35% | -20.55% | 6.80% | Upgrade
|
| Free Cash Flow | - | 231.83 | 239.82 | 132.26 | 113.14 | 163.07 | Upgrade
|
| Free Cash Flow Per Share | - | 15.53 | 16.06 | 8.86 | 8.42 | 12.85 | Upgrade
|
| Dividend Per Share | - | 8.022 | 8.650 | - | - | - | Upgrade
|
| Dividend Growth | - | -7.26% | - | - | - | - | Upgrade
|
| Gross Margin | - | 79.71% | 76.75% | 87.28% | 92.08% | 91.73% | Upgrade
|
| Operating Margin | - | 54.31% | 51.86% | 58.47% | 57.60% | 63.78% | Upgrade
|
| Profit Margin | - | 38.55% | 56.69% | 50.60% | 49.98% | 58.43% | Upgrade
|
| Free Cash Flow Margin | - | 91.03% | 90.20% | 54.51% | 47.42% | 67.21% | Upgrade
|
| EBITDA | - | 142.13 | 142.04 | 148.31 | 141.02 | 161.07 | Upgrade
|
| EBITDA Margin | - | 55.81% | 53.42% | 61.13% | 59.10% | 66.38% | Upgrade
|
| D&A For EBITDA | - | 3.81 | 4.15 | 6.45 | 3.59 | 6.33 | Upgrade
|
| EBIT | - | 138.32 | 137.9 | 141.86 | 137.43 | 154.74 | Upgrade
|
| EBIT Margin | - | 54.31% | 51.86% | 58.47% | 57.60% | 63.78% | Upgrade
|
| Revenue as Reported | - | - | - | 242.63 | 238.59 | 242.64 | Upgrade
|
| Advertising Expenses | - | 17.11 | 15.86 | 8.17 | 10.67 | 6.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.